标题
Genetics of antipsychotic-induced weight gain: update and current perspectives
作者
关键词
-
出版物
PHARMACOGENOMICS
Volume 14, Issue 16, Pages 2067-2083
出版商
Future Medicine Ltd
发表日期
2013-11-26
DOI
10.2217/pgs.13.207
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The pharmacogenetics of antipsychotic-induced adverse events
- (2013) Daniel J. Müller et al. CURRENT OPINION IN PSYCHIATRY
- Exploratory study on association of genetic variation inTBC1D1with antipsychotic-induced weight gain
- (2013) Eva J. Brandl et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- History of the Discovery of the Antipsychotic Dopamine D2 Receptor: A Basis for the Dopamine Hypothesis of Schizophrenia
- (2013) Bertha K. Madras Journal of the History of the Neurosciences
- Proteomic profiling in schizophrenia: enabling stratification for more effective treatment
- (2013) Paul C Guest et al. Genome Medicine
- Moderation of antipsychotic-induced weight gain by energy balance gene variants in the RUPP autism network risperidone studies
- (2013) E L Nurmi et al. Translational Psychiatry
- The Rab-GTPase-activating protein TBC1D1 regulates skeletal muscle glucose metabolism
- (2012) Ferenc Szekeres et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Association Between Common Variants Near the Melanocortin 4 Receptor Gene and Severe Antipsychotic Drug–Induced Weight Gain
- (2012) Anil K. Malhotra ARCHIVES OF GENERAL PSYCHIATRY
- Association between Ghrelin gene (GHRL) polymorphisms and clinical response to atypical antipsychotic drugs in Han Chinese schizophrenia patients
- (2012) Yongfeng Yang et al. Behavioral and Brain Functions
- Increased feeding and body weight gain in rats after acute and chronic activation of RXFP3 by relaxin-3 and receptor-selective peptides
- (2012) Despina E. Ganella et al. BEHAVIOURAL PHARMACOLOGY
- Influence of ANKK1 and DRD2 polymorphisms in response to haloperidol
- (2012) Ina Giegling et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- The obesity risk gene FTO influences body mass in chronic schizophrenia but not initial antipsychotic drug-induced weight gain in first-episode patients
- (2012) Gavin P. Reynolds et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Pharmacogenomic Associations With Weight Gain in Olanzapine Treatment of Patients Without Schizophrenia
- (2012) John P. Houston et al. JOURNAL OF CLINICAL PSYCHIATRY
- Risk Factors Associated With Metabolic Syndrome in Bipolar and Schizophrenia Subjects Treated With Antipsychotics
- (2012) Vicki L. Ellingrod et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Association of a Functional Polymorphism in Neuropeptide Y With Antipsychotic-Induced Weight Gain in Schizophrenia Patients
- (2012) Arun K. Tiwari et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Association of the Common MC4R rs17782313 Polymorphism With Antipsychotic-Related Weight Gain
- (2012) Fabian Czerwensky et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- The Effects of DBH, MAOA, and MAOB on Attentional Biases for Facial Expressions
- (2012) Pingyuan Gong et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Association study between variants of AMP-activated protein kinase catalytic and regulatory subunit genes with antipsychotic-induced weight gain
- (2012) Renan P. Souza et al. JOURNAL OF PSYCHIATRIC RESEARCH
- AMPK and the neuroendocrine regulation of appetite and energy expenditure
- (2012) Romana Stark et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Peroxisome Proliferator-Activated Receptor Gamma (PPARG) Pro12Ala
- (2012) Julia Staeker et al. Molecular Diagnosis & Therapy
- Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents
- (2012) S Miyamoto et al. MOLECULAR PSYCHIATRY
- AMPK: a nutrient and energy sensor that maintains energy homeostasis
- (2012) D. Grahame Hardie et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Clozapine, atypical antipsychotics, and the benefits of fast-off D2 dopamine receptor antagonism
- (2012) Georges Vauquelin et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Strengths and weaknesses of pharmacogenetic studies of antipsychotic drugs: the potential value of the PEPs study
- (2012) Sergi Mas et al. PHARMACOGENOMICS
- Association of theMTHFRgene with antipsychotic-induced metabolic abnormalities in patients with schizophrenia
- (2012) Martina Rojnic Kuzman et al. PHARMACOGENOMICS
- Association of common genetic variants with risperidone adverse events in a Spanish schizophrenic population
- (2012) B Almoguera et al. PHARMACOGENOMICS JOURNAL
- Genetic association study between antipsychotic-induced weight gain and the melanocortin-4 receptor gene
- (2012) N I Chowdhury et al. PHARMACOGENOMICS JOURNAL
- Cardiovascular side-effects of antipsychotic drugs: The role of the autonomic nervous system
- (2012) Joanne Y.T. Leung et al. PHARMACOLOGY & THERAPEUTICS
- Possible impact of ADRB3 Trp64Arg polymorphism on BMI in patients with schizophrenia
- (2012) Daimei Sasayama et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Association study of polymorphisms in leptin and leptin receptor genes with antipsychotic-induced body weight gain
- (2012) E.J. Brandl et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- The current state of play on the molecular genetics of depression
- (2012) S. Cohen-Woods et al. PSYCHOLOGICAL MEDICINE
- Serotonin–glutamate and serotonin–dopamine reciprocal interactions as putative molecular targets for novel antipsychotic treatments: from receptor heterodimers to postsynaptic scaffolding and effector proteins
- (2012) A. de Bartolomeis et al. PSYCHOPHARMACOLOGY
- Pro12Ala polymorphism of the PPAR-γ2 gene, metabolic syndrome and response to metformin in clozapine-treated patients
- (2012) Erika Fernández et al. SCHIZOPHRENIA RESEARCH
- Acute and maintenance effects of non-pharmacologic interventions for antipsychotic associated weight gain and metabolic abnormalities: A meta-analytic comparison of randomized controlled trials
- (2012) Jacqueline Caemmerer et al. SCHIZOPHRENIA RESEARCH
- Cardiometabolic risk and the MTHFR C677T variant in children treated with second-generation antipsychotics
- (2012) A M Devlin et al. Translational Psychiatry
- Using a pharmacogenomic algorithm to guide the treatment of depression
- (2012) D K Hall-Flavin et al. Translational Psychiatry
- Pharmacogenetic Aspects of Antipsychotic Drug-induced Weight Gain - A Critical Review
- (2012) Gavin P. Reynolds Clinical Psychopharmacology and Neuroscience
- Interventions for the metabolic syndrome in schizophrenia: a review
- (2012) Evangelos Papanastasiou Therapeutic Advances in Endocrinology and Metabolism
- Exercise increases TBC1D1 phosphorylation in human skeletal muscle
- (2011) Niels Jessen et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Pharmacogenetics of Response to Antipsychotics in Patients with Schizophrenia
- (2011) Maria J. Arranz et al. CNS DRUGS
- Characterization of the Hyperphagic Response to Dietary Fat in the MC4R Knockout Mouse
- (2011) Dollada Srisai et al. ENDOCRINOLOGY
- Effects of olanzapine on muscarinic M3 receptor binding density in the brain relates to weight gain, plasma insulin and metabolic hormone levels
- (2011) Katrina Weston-Green et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Association of serum levels of leptin, ghrelin, and adiponectin in schizophrenic patients and healthy controls
- (2011) Meng-Chang Tsai et al. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
- Relaxin polymorphisms associated with metabolic disturbance in patients treated with antipsychotics
- (2011) Janet Munro et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications
- (2011) T A P Lett et al. MOLECULAR PSYCHIATRY
- Association Study of Brain-Derived Neurotrophic Factor Gene Polymorphisms and Body Weight Change in Schizophrenic Patients Under Long-Term Atypical Antipsychotic Treatment
- (2011) Ashley Tsai et al. NEUROMOLECULAR MEDICINE
- TNF-α −308 G>A polymorphism and weight gain in patients with schizophrenia under long-term clozapine, risperidone or olanzapine treatment
- (2011) Hsiang-Hsuan Huang et al. NEUROSCIENCE LETTERS
- Functional consequences of twoHTR2Cpolymorphisms associated with antipsychotic-induced weight gain
- (2011) Matthew J Hill et al. PHARMACOGENOMICS
- Pharmacogenetics of leptin in antipsychotic-associated weight gain and obesity-related complications
- (2011) Amy K Lee et al. PHARMACOGENOMICS
- Pharmacogenetic testing to predict antipsychotic-induced weight gain: a systematic review
- (2011) Arne J Risselada et al. PHARMACOGENOMICS
- Polymorphisms of the LEP, LEPR and HTR2C gene: obesity and BMI change in patients using antipsychotic medication in a naturalistic setting
- (2011) Jochem G Gregoor et al. PHARMACOGENOMICS
- Stress and Affective Disorders: Animal Models Elucidating the Molecular Basis of Neuroendocrine-Behavior Interactions
- (2011) C. Touma PHARMACOPSYCHIATRY
- A Double Blind, Placebo-Controlled, Randomized Crossover Study of the Acute Metabolic Effects of Olanzapine in Healthy Volunteers
- (2011) Vance L. Albaugh et al. PLoS One
- Sterol-induced degradation of HMG CoA reductase depends on interplay of two Insigs and two ubiquitin ligases, gp78 and Trc8
- (2011) Y. Jo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Weight gain and ghrelin level after olanzapine monotherapy
- (2011) Vincent Chin-Hung Chen et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Association between the ROBO1 gene and body mass index in patients using antipsychotics
- (2011) Jelle Vehof et al. PSYCHIATRIC GENETICS
- Genetic Polymorphisms in the HTR2C and Peroxisome Proliferator-Activated Receptors Are Not Associated with Metabolic Syndrome in Patients with Schizophrenia Taking Clozapine
- (2011) Shi Hyun Kang et al. Psychiatry Investigation
- Acute effects of orexigenic antipsychotic drugs on lipid and carbohydrate metabolism in rat
- (2011) Goran Jassim et al. PSYCHOPHARMACOLOGY
- Association of genetic variants of the histamine H1 and muscarinic M3 receptors with BMI and HbA1c values in patients on antipsychotic medication
- (2011) Jelle Vehof et al. PSYCHOPHARMACOLOGY
- Involvement of histamine receptors in the atypical antipsychotic profile of clozapine: a reassessment in vitro and in vivo
- (2011) Marie Humbert-Claude et al. PSYCHOPHARMACOLOGY
- Relaxin family peptide systems and the central nervous system
- (2010) G. E. Callander et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Genetic association between TNF-α −308 G>A polymorphism and longitudinal weight change during clozapine treatment
- (2010) Ying-Chieh Wang et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Clozapine activates AMP-activated protein kinase (AMPK) in C2C12 myotube cells and stimulates glucose uptake
- (2010) Ji Hae Kim et al. LIFE SCIENCES
- A theoretical molecular network for dyslexia: integrating available genetic findings
- (2010) G Poelmans et al. MOLECULAR PSYCHIATRY
- Polymorphisms of theHTR2Cgene and antipsychotic-induced weight gain: an update and meta-analysis
- (2010) Michelle N Sicard et al. PHARMACOGENOMICS
- Systematic analysis of dopamine receptor genes (DRD1–DRD5) in antipsychotic-induced weight gain
- (2010) D J Müller et al. PHARMACOGENOMICS JOURNAL
- Gene–gene interactions of the INSIG1 and INSIG2 in metabolic syndrome in schizophrenic patients treated with atypical antipsychotics
- (2010) Y-J Liou et al. PHARMACOGENOMICS JOURNAL
- Association between HTR2C gene polymorphisms and the metabolic syndrome in patients using antipsychotics: a replication study
- (2010) A J Risselada et al. PHARMACOGENOMICS JOURNAL
- Effects of olanzapine on brain-derived neurotrophic factor gene promoter activity in SH-SY5Y neuroblastoma cells
- (2010) Jung Goo Lee et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- MTHFR and risk of metabolic syndrome in patients with schizophrenia
- (2010) Ruud van Winkel et al. SCHIZOPHRENIA RESEARCH
- The genetics of obesity: FTO leads the way
- (2010) Katherine A. Fawcett et al. TRENDS IN GENETICS
- Evidence for an effect of clozapine on the regulation of fat-cell derived factors
- (2009) Zhi Yang et al. CLINICA CHIMICA ACTA
- The Q223R polymorphism in LEPR is associated with obesity in Pacific Islanders
- (2009) Takuro Furusawa et al. HUMAN GENETICS
- Body weight gain induced by atypical antipsychotics: an extension of the monocygotic twin and sib pair study
- (2009) S. Gebhardt et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Multiple Genetic Factors in Olanzapine-Induced Weight Gain in Schizophrenia Patients
- (2009) Hiroshi Ujike et al. JOURNAL OF CLINICAL PSYCHIATRY
- HTR2C Gene Polymorphisms and the Metabolic Syndrome in Patients With Schizophrenia
- (2009) Hans Mulder et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- INSIG1influences obesity-related hypertriglyceridemia in humans
- (2009) E. M. Smith et al. JOURNAL OF LIPID RESEARCH
- Folate, homocysteine, interleukin-6, and tumor necrosis factor alfa levels, but not the methylenetetrahydrofolate reductase C677T polymorphism, are risk factors for schizophrenia
- (2009) María del Rosario García-Miss et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Metabolic side effects of antipsychotic drug treatment – pharmacological mechanisms
- (2009) Gavin P Reynolds et al. PHARMACOLOGY & THERAPEUTICS
- The Neurodevelopmental Hypothesis of Schizophrenia, Revisited
- (2009) S. H. Fatemi et al. SCHIZOPHRENIA BULLETIN
- C957T polymorphism of dopamine D2 receptor gene affects striatal DRD2 in vivo availability by changing the receptor affinity
- (2009) Mika M. Hirvonen et al. SYNAPSE
- On the Replication of Genetic Associations: Timing Can Be Everything!
- (2008) Jessica Lasky-Su et al. AMERICAN JOURNAL OF HUMAN GENETICS
- R125W coding variant in TBC1D1 confers risk for familial obesity and contributes to linkage on chromosome 4p14 in the French population
- (2008) D. Meyre et al. HUMAN MOLECULAR GENETICS
- Performance of a neuro-fuzzy model in predicting weight changes of chronic schizophrenic patients exposed to antipsychotics
- (2008) T H Lan et al. MOLECULAR PSYCHIATRY
- Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects?
- (2008) S Le Hellard et al. MOLECULAR PSYCHIATRY
- Tbc1d1 mutation in lean mouse strain confers leanness and protects from diet-induced obesity
- (2008) Alexandra Chadt et al. NATURE GENETICS
- Impact of atypical antipsychotic therapy on leptin, ghrelin, and adiponectin
- (2008) Hua Jin et al. SCHIZOPHRENIA RESEARCH
- Metabolic syndrome and insulin resistance in schizophrenia patients receiving antipsychotics genotyped for the methylenetetrahydrofolate reductase (MTHFR) 677C/T and 1298A/C variants
- (2008) Vicki L. Ellingrod et al. SCHIZOPHRENIA RESEARCH
- Mutations in ligands and receptors of the leptin–melanocortin pathway that lead to obesity
- (2008) I Sadaf Farooqi et al. Nature clinical practice. Endocrinology & metabolism
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now